In our study, none of the patients with EGFR mutation had an ALK gene rearrangement (data not shown), which is in line with the literature, indicating that EML4-ALK fusion tends to occur in adenocarcinomas lacking EGFR mutation [17, 19, 26–29]. This evidence concerns the gene ALK and adenocarcinoma.